Lycopene
Manual Download
Cat.No：IL0510 Solarbio
CAS：502-65-8
Storage：Powder:-20℃，1 year
Purity：HPLC≥90%
Appearance：Red to reddish brown Solid
Qty：
-
+
Size：
{{cart_num}}
My CartTel: +86 010 50973105
Products
Secondary Antibodies
SAlexa Fluor-Conjugated
Other Fluorescent-Conjugated
Other-Conjugated
Colloidal Gold Reagent
Alkaline Phosphatase(AP)-Conjugated
Colloidal Gold-Conjugated
FITC-Conjugated
Biotin-Conjugated
Purified Secondary Antibodies
Allophycocyanin(APC)-Conjugated
CY Fluorescent-Conjugated
Phycoglobin(PE)-Conjugated
RBTIC-Conjugated
Peroxidase (HRP)-Conjugated
Secondary Antibodies
SAlexa Fluor-Conjugated
Other Fluorescent-Conjugated
Other-Conjugated
Colloidal Gold Reagent
Alkaline Phosphatase(AP)-Conjugated
Colloidal Gold-Conjugated
FITC-Conjugated
Biotin-Conjugated
Purified Secondary Antibodies
Allophycocyanin(APC)-Conjugated
CY Fluorescent-Conjugated
Phycoglobin(PE)-Conjugated
RBTIC-Conjugated
Peroxidase (HRP)-Conjugated
Inhibitors & Antagonists & Agonists
PI3K/Akt/mTOR
Endocrinology & Hormones
Protein Tyrosine Kinase/PTK
Angiogenesis
HIF
Immunology & Inflammation
Stem Cells
Apoptosis
Metabolic Enzyme & Protease
Autophagy
ER Stress
Cell Cycle
Cytoskeleton
DNA Damage & DNA Repai
Epigenetics
Ubiquitin
JAK/STAT
GPCR & G Protein
Neuronal Signal Pathway
MAPK
NF-κB
Membrane Transporter & Ion Channel
TGF-β/Smad
Hippo
Antibody-drug Conjugate/ADC Related
Others
Inhibitors & Antagonists & Agonists
PI3K/Akt/mTOR
Endocrinology & Hormones
Protein Tyrosine Kinase/PTK
Angiogenesis
HIF
Immunology & Inflammation
Stem Cells
Apoptosis
Metabolic Enzyme & Protease
Autophagy
ER Stress
Cell Cycle
Cytoskeleton
DNA Damage & DNA Repai
Epigenetics
Ubiquitin
JAK/STAT
GPCR & G Protein
Neuronal Signal Pathway
MAPK
NF-κB
Membrane Transporter & Ion Channel
TGF-β/Smad
Hippo
Antibody-drug Conjugate/ADC Related
Others
Instruments
Pipette & Dispenser & Pipette Dispensing Instrument
Oscillating Mixing & Stirring & Dispersing Instrument
Temperature Control & Sampling & Grinding Crushing Instrument
Sterilization & Filtration Instruments
PCR Instrument & Light Glue Instrument
Spectrophotometer
Centrifuge
Shaker
Vacuum Pump
Other Small Instruments
Instruments
Pipette & Dispenser & Pipette Dispensing Instrument
Oscillating Mixing & Stirring & Dispersing Instrument
Temperature Control & Sampling & Grinding Crushing Instrument
Sterilization & Filtration Instruments
PCR Instrument & Light Glue Instrument
Spectrophotometer
Centrifuge
Shaker
Vacuum Pump
Other Small Instruments
Your Position: Home
> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Immunology & Inflammation > Lycopene
Product Information
| CAS | 502-65-8 |
| Name | Lycopene |
| Molecular Formula | C40H56 |
| Molecular Weight | 536.87 |
| Solubility | Soluble in Chloroform ≥1mg/mL(The product is easily oxidized, so it is recommended to use it now) |
| Purity | HPLC≥90% |
| Appearance | Red to reddish brown Solid |
| Storage | Powder:-20℃，1 year |
| EC | EINECS 207-949-1 |
| MDL | MFCD00017350 |
| SMILES | C/C(C)=C\CC/C(C)=C/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(/C=C/C=C(C)/C=C/C=C(CC/C=C(C)\C)\C)C |
| Target Point | Reactive oxygen species (ROS) |
| Passage | Immunology & Inflammation |
| Background | It is a carotenoid. The long-chain polyunsaturated olefin molecular structure has strong ability to eliminate free radicals and anti-oxidation. |
| Biological Activity | Lycopene是番茄，番茄产品和其他红色水果和蔬菜中天然存在的类胡萝卜素; 具有抗氧化作用。[1-5] |
| In Vitro | 由于人类无法从头合成番茄红素，因此必须从饮食中充分摄取番茄红素以从其健康促进效果中受益。番茄红素在1.25μM的生理相关浓度下显着抑制前列腺癌和乳腺癌细胞生长，并且还导致细胞中κB磷酸化抑制剂减少30-40％[1]。西红柿中一种主要类胡萝卜素的番茄红素的摄入量增加，作为全反式异构体消耗减少酒精诱导的2E1细胞凋亡并降低前列腺癌，肺癌和消化道癌症的风险。番茄红素通过作为单线态分子氧和过氧自由基清除剂起到防光氧化过程的作用，并且可以与其他抗氧化剂协同作用[2]。作为类胡萝卜素的番茄红素可以以三种不同的机制与活性氧物质(ROS)的类型反应：I)通过电子转移，II)通过氢原子转移或III)通过加合物形成。番茄红素能够主要通过物理猝灭使单线态氧失活[3]。番茄红素通过抑制PKC途径引起的NADPH氧化酶降低SK-Hep-1细胞中的ROS产生[5]。 |
| In Vivo | 番茄红素是人血浆中最主要的类胡萝卜素，半衰期约为2-3天[2]。番茄红素或加工番茄可能导致血管壁内膜中层厚度减少[3]。番茄红素对大鼠肾上腺皮质中ATZ诱导的毒性具有保护作用。这些影响可能归因于番茄红素的抗氧化特性及其激活Nrf2 / HO-1途径的能力[4]。番茄红素可改善肝毒性，起抗氧化剂作用，降低GSSG，调节tGSH和CAT水平，减少氧化损伤[5]。 |
| Cell Experiment | 用(0，0.5，1.25，2.5和5μM)番茄红素处理PC3细胞和MDA-MB-231细胞48小时。使用比色MTS测定方法测量细胞存活/生长。向每个孔中加入MTS-PMS复合物(20μL)。活细胞的催化活性导致甲dye染料产生，然后量化。将细胞与染料一起孵育1小时，然后在分光光度计上读取492nm处的吸光度[1]。 |
| Animal Experiment | 大鼠：番茄红素溶解在玉米油中。将35只成年雄性白化病大鼠随机分成5组：未处理对照组，媒介物对照组(每天接受0.5毫升玉米油)，番茄红素(10毫克/千克体重/天)，ATZ(溶于0.5毫升玉米油300毫克/千克)bw /天)和ATZ +番茄红素。所有治疗均通过口服强饲法治疗4周[4]。 |
| Data Literature Source | [1]. Assar EA， et al. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells. Tumour Biol. 2016 Jul; 37 (7) :9375-85. [2]. Tapiero H， et al. The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother. 2004 Mar; 58 (2) :100-10. [3]. Müller L， et al. Lycopene and Its Antioxidant Role in the Prevention of Cardiovascular Diseases-A Critical Review. Crit Rev Food Sci Nutr. 2016 Aug 17; 56 (11) :1868-79. [4]. Abass MA， et al. Lycopene ameliorates atrazine-induced oxidative damage in adrenal cortex of male rats by activation of the Nrf2/HO-1 pathway. Environ Sci Pollut Res Int. 2016 Aug; 23 (15) :15262-74. [5]. Bandeira AC， et al. Lycopene inhibits reactive oxygen species production in SK-Hep-1 cells and attenuates acetaminophen-induced liver injury in C57BL/6 mice. Chem Biol Interact. 2017 Feb 1; 263:7-17. |
| Unit | Bottle |
| Specification | 10mg 20mg 50mg |
Examples of using this product（for reference only）
In Vitro：
Cell（mouse microvascular cerebral endothelial cells/bEnd.3；lycopene（0.25% BHT in THF））:
For the In Vitro experiment, we grew mouse microvascular cerebral endothelial cells (bEnd.3) in Dulbecco’s modified Eagle's medium (DMEM) supplemented with 10% FBS and 1% 100 U/mL penicillin and 100 U/mL streptomycin. Cultures were maintained under 5% CO2 at 37℃. We dissolved lycopene (Solarbio, China) in tetrahydrofuran (THF) containing 0.25% butylated hydroxytoluene (BHT) and stored it at -80℃ in 4 mM stock. On Day 5 of bEnd. 3 culture, the medium was replaced with pre-warmed PBS and then divided into a control group (solvent group), Ly294002 treatment group (10 mM; inhibitor group), and lycopene t Ly294002 group (lycopene t inhibitor group). The control group was treated with the same dose of FBS and double antibody (0.25% BHT in THF) to offset any possible interference. The lycopene t inhibitor group was pretreated with Ly294002 for 30 min and then treated with lycopene for 24 h.
Reference：
Xu XD, Teng Y, Zou JY, Ye Y, Song H, Wang ZY. Effects of lycopene on vascular remodeling through the LXR-PI3K-AKT signaling pathway in APP/PS1 mice. Biochem Biophys Res Commun. 2020 Jun 4;526(3):699-705. doi: 10.1016/j.bbrc.2020.02.063. Epub 2020 Apr 3. PMID: 32253029.
Cell（H9c2 cells，2.5~40 μM LP, 12h）:
Firstly, H9c2 cells were randomly divided into 8 groups at the first phase as follows: (i) control group (Control): H9c2 cells were incubated in normoxic conditions at 37℃ in a cell culture incubator for 13 hrs; (ii) hypoxia/re-oxygenation group (H/R): H9c2 cells were subjected to hypoxia for 12 hrs followed by reoxygenation for 1 hr; (iii) solvent group (Vehicle): H9c2 cells were pretreated with 0.1% DMSO for 12 hrs and underwent HR group procedures; (iv)–(viii) 2.5 μM LP pretreatment group (LP 2.5 μM), 5 μM LP pretreatment group (LP 5 μM), 10 μM LP pretreatment group (LP 10 μM), 20 μM LP pretreatment group (LP 20 μM), 40 μM LP pretreatment group(LP 40 μM): H9c2 cells were pretreated with LP at the dose of 2.5 μM, 5 μM, 10 μM, 20 μM and 40 μM for 12 hrs and underwent HR group procedures.
In the second phase (according to the result of first phase), 10 μM LP was selected to explore the mechanism further. Therefore, H9c2 cells were further divided into 4 groups as follows: (i) Control group; (ii) HR group; (iii)LP 10 μM group; (iv) LP 10 μM combined with ATR pretreatment group (LP 10 μM + ATR): H9c2 cells were pretreated with 10 μM LP and 20 μM ATR for 12 hrs and underwent HR group procedures.
Reference：
Li X, Jia P, Huang Z, Liu S, Miao J, Guo Y, Wu N, Jia D. Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Drug Des Devel Ther. 2019 Jul 11;13:2331-2342. doi: 10.2147/DDDT.S194753. PMID: 31371925; PMCID: PMC6635826.
In Vivo：
Mice（9-month-old APP/PS1 mice，4 mg/kg lycopene）:
We randomly assigned 12 APP/PS1 transgenic mice to two groups: APP/PS1+solvent (APP/PS1; AD group; n=6) and AD+4 mg/kg lycopene (LY; drug group; n = 6). Similarly, we randomly selected six WT C57/BL6J mice as the wild control group (WT group).
Reference：
Xu XD, Teng Y, Zou JY, Ye Y, Song H, Wang ZY. Effects of lycopene on vascular remodeling through the LXR-PI3K-AKT signaling pathway in APP/PS1 mice. Biochem Biophys Res Commun. 2020 Jun 4;526(3):699-705. doi: 10.1016/j.bbrc.2020.02.063. Epub 2020 Apr 3. PMID: 32253029.
Rat（10~40 mg/kg LP，1次/d，共5 d，I.P；experimental group: 40 mg/ kg LP in Corn Oil）:
In the first phase, 30 rats were divided into the following 5 groups with 6 rats per group: (i) ischemia-reperfusion group (IR): As described above; (ii) solvent group (Vehicle): The rats were pretreated with 2 mL medicinal corn oil by intraperitoneal injection once per day for 5 days, and underwent IR procedures; (iii–v) 10 mg/kg LP pretreatment group (LP 10 mg/kg), 20 mg/kg LP pretreatment group (LP 20 mg/kg), 40 mg/kg LP pretreatment group (LP 40 mg/kg): The rats were pretreated with 10, 20, 40 mg/kg LP by intraperitoneal injection once per day, for a total of 5 days, and underwent IR group procedures.
In the second phase (according to the results in the first phase), 40 mg/kg LP was selected as the most appropriate dose. A total of 80 rats were divided into the following 4 groups with 20 rats per group in the second phase: (i) IR group; (ii) Vehicle group; (iii) LP 40 mg/kg group; (iv) 40 mg/kg LP in combination with ATR pretreatment group (LP 40 mg/kg + ATR): 5 mg/kg ATR was injected intraperitoneally 30 mins prior to extraction of the heart, and the remainder of the procedure was as described for the LP 40 mg/kg group.
Reference：
Li X, Jia P, Huang Z, Liu S, Miao J, Guo Y, Wu N, Jia D. Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Drug Des Devel Ther. 2019 Jul 11;13:2331-2342. doi: 10.2147/DDDT.S194753. PMID: 31371925; PMCID: PMC6635826.
Mice（healthy male kunming mice (6 weeks old) weighing 23–28 g；5 mg/kg LYC（1 mg/mL的悬浮液），Gavage；溶剂：橄榄油）:
After an acclimatization period of a week, the mice were divided into four groups, ten in each. The mice were treated for 30 days as follows: Group 1 (CG) was orally administered with the vehicle (0.2 mL olive oil). Group 2 (AG) was orally administrated with AFB1 (≥ 99.8%) at 0.75 mg/kg. Group 3 (ALG) were treated with LYC (≥ 98%, Solarbio, Beijing, China) at 5 mg/kg 2 h prior to AFB1 administration, then given AFB1 at 0.75 mg/kg. Group 4(LG) was orally administrated with LYC at 5 mg/kg. AFB1 and LYC were administered by gavage in olive oil and made into suspension at the concentrations of 0.2 mg/mL and 1 mg/mL, respectively. The general health was monitored daily.
Reference：
Zhang J, Wang P, Xu F, Huang W, Ji Q, Han Y, Shao B, Li Y. Protective effects of lycopene against AFB1-induced erythrocyte dysfunction and oxidative stress in mice. Res Vet Sci. 2020 Apr;129:103-108. doi: 10.1016/j.rvsc.2020.01.015. Epub 2020 Jan 13. PMID: 31954314.
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Experimental Images
Sorry, there is no more information.
Li X, et al. Drug Des Devel Ther. 2019 Jul 11;132331-2342
Li X, et al. Drug Des Devel Ther. 2019 Jul 11;132331-2342
Li X, et al. Drug Des Devel Ther. 2019 Jul 11;132331-2342
Xu XD, et al. Biochem Biophys Res Commun. 2020 Jun 4;526(3)699-705.
Li X, et al. Drug Des Devel Ther. 2019 Jul 11;132331-2342.
Xu XD, et al. Biochem Biophys Res Commun. 2020 Jun 4;526(3)699-705.
Xu XD, et al. Biochem Biophys Res Commun. 2020 Jun 4;526(3)699-705.
Related Products
Sorry, there is no more information.
Related Paper
Lycopene protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening
Click to check >>Author：Li X; Jia P; Huang Z; Liu S; Miao J; Guo Y; Wu N;
IF：3.3490
Publish_to：Drug Des Devel Ther
PMID：31371925
Effects of lycopene on vascular remodeling through the LXR-PI3K-AKT signaling pathway in APP/PS1 mice
Click to check >>Author：Xu XD; Teng Y; Zou JY; Ye Y; Song H; Wang ZY
IF：3.3070
Publish_to：Biochem Biophys Res Commun
PMID：32253029
Protective effects of lycopene against AFB1-induced erythrocyte dysfunction and oxidative stress in mice
Click to check >>Author：Zhang J; Wang P; Xu F; Huang W; Ji Q; Han Y; Shao
IF：2.3720
Publish_to：Res Vet Sci
PMID：31954314
Technical Q&A
Q&A
（Total 0
User Q&A）
- There is not question and answer now, come and send an inquiry please.
My question
Service for Scientific Research, Responsible for the Life Science
Contact Us
Address: No 85, Liandong U Valley, Middle Zone, 101102, Tongzhou Dist,
Beijing, China
Tel: +86 010 50973105
Email: [email protected]
Order Guide
Service Guarantee
Resources Download
Copyright © 2005-2021 Solarbio all rights reserved.